Craft, SamDunn, MichaelVidler, DanOfficer, JaneBlagbrough, Ian SPudney, Christopher RHenderson, GraemeAbouzeid, AhmedDargan, Paul IEddleston, MichaelCooper, JamieHill, Simon LRoper, ClairFreeman, Tom PThomas, Simon H L2025-11-252022-11Craft, S, Dunn, M, Vidler, D, Officer, J, Blagbrough, I S, Pudney, C R, Henderson, G, Abouzeid, A, Dargan, P I, Eddleston, M, Cooper, J, Hill, S L, Roper, C, Freeman, T P & Thomas, S H L 2022, 'Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act', Addiction, vol. 117, no. 11, pp. 2899-2906. https://doi.org/10.1111/add.159670965-2140PubMedCentral: PMC9796520https://hdl.handle.net/2164/26472We acknowledge with gratitude the work done by the research staff in all IONA sites and thank all the participants for allowing their data and samples to be used for this study.81241353engCannabinoid Receptor Agonists/adverse effectsChromatography, LiquidFemaleHospitalsHumansMalePersonalityUnited Kingdom/epidemiologyR Medicine (General)R1Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances ActJournal article10.1111/add.15967